Jiahui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiahui Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bin Li
Gansu Provincial Key Laboratory of Microbial Resources Utilization and Development, Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China
1 shared publication - Chen Li
Gansu Provincial Key Laboratory of Microbial Resources Utilization and Development, Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China
1 shared publication - Qingqing Yao
Gansu Provincial Key Laboratory of Microbial Resources Utilization and Development, Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China
1 shared publication - Qiuyan Xiang
College of Agronomy and Biotechnology, China Agricultural University, No 2 Yuanmingyuan West Road, Haidian District, Beijing 100193, China
1 shared publication - Weiwen Lu
Gansu Provincial Key Laboratory of Microbial Resources Utilization and Development, Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China
1 shared publication - Zhiye Wang
Gansu Provincial Key Laboratory of Microbial Resources Utilization and Development, Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 10 June 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (6) , 402
Advances in UDP-Glycosyltransferases from Medicinal Plants: Discovery, Catalytic Mechanism, Engineering and Biosynthetic Application
Glycosylation is a critical structural modification that shapes the pharmacological properties of bioactive ingredients from Traditional Chinese Medicine (TCM), and UDP-glycosyltransferases (UGTs) are the core rate-limiting biocatalysts mediating this process. Traditional plant extraction methods are constrained by resource scarcity, long growth cycles, low target content and high environmental costs, which cannot meet the large-scale industrial demand for high-value medicinal glycosides. This review systematically outlines the latest global advances in medicinal plant UGT research, covering family classification and physiological functions, multi-omics and AI-assisted gene mining, molecular basis of substrate recognition and catalytic specificity, protein engineering for performance optimization, and the construction of full-spectrum biomanufacturing systems including in vitro multi-enzyme cascades, microbial cell factories and plant suspension cell cultures. We further discuss the core challenges of industrial scale-up, regulatory compliance and clinical translation, as well as the significant economic and technical advantages of synthetic biology-based UGT biomanufacturing platforms. This work provides a complete technical framework for the engineering application of medicinal plant UGTs, to support the green and scalable production of rare natural therapeutic glycosides.
- 10 June 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (6) , 402
Top Cited PapersOpen AccessAdvances in UDP-Glycosyltransferases from Medicinal Plants: Discovery, Catalytic Mechanism, Engineering and Biosynthetic Application
Glycosylation is a critical structural modification that shapes the pharmacological properties of bioactive ingredients from Traditional Chinese Medicine (TCM), and UDP-glycosyltransferases (UGTs) are the core rate-limiting biocatalysts mediating this process. Traditional plant extraction methods are constrained by resource scarcity, long growth cycles, low target content and high environmental costs, which cannot meet the large-scale industrial demand for high-value medicinal glycosides. This review systematically outlines the latest global advances in medicinal plant UGT research, covering family classification and physiological functions, multi-omics and AI-assisted gene mining, molecular basis of substrate recognition and catalytic specificity, protein engineering for performance optimization, and the construction of full-spectrum biomanufacturing systems including in vitro multi-enzyme cascades, microbial cell factories and plant suspension cell cultures. We further discuss the core challenges of industrial scale-up, regulatory compliance and clinical translation, as well as the significant economic and technical advantages of synthetic biology-based UGT biomanufacturing platforms. This work provides a complete technical framework for the engineering application of medicinal plant UGTs, to support the green and scalable production of rare natural therapeutic glycosides.